How Much Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Do Insiders Own?
How Much Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Do Insiders Own?
Every investor in Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don't tell me what you think, tell me what you have in your portfolio.
深圳邁瑞生物醫療電子有限公司（SZSE: 300760）的每位投資者都應該了解最強大的股東群體。機構通常會持有大公司的股票，我們預計內部人士將持有相當比例的小型公司的股票。我通常希望看到一定程度的內部所有權，即使只是一點點。正如納西姆·尼古拉斯·塔勒布所說：“不要告訴我你的想法，告訴我你的投資組合中有什麼。
Shenzhen Mindray Bio-Medical Electronics is a pretty big company. It has a market capitalization of CN¥370b. Normally institutions would own a significant portion of a company this size. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Shenzhen Mindray Bio-Medical Electronics.
深圳邁瑞生物醫療電子是一家相當大的公司。它的市值爲370億元人民幣。通常，機構將擁有如此規模的公司的很大一部分股份。看看我們關於所有權群體的數據（見下文），機構投資者似乎已經收購了該公司。我們可以放大不同的所有權群體，以了解有關深圳邁瑞生物醫療電子的更多信息。
See our latest analysis for Shenzhen Mindray Bio-Medical Electronics
查看我們對深圳邁瑞生物醫療電子的最新分析
What Does The Institutional Ownership Tell Us About Shenzhen Mindray Bio-Medical Electronics?
關於深圳邁瑞生物醫療電子，機構所有權告訴我們什麼？
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
許多機構根據接近當地市場的指數來衡量其表現。因此，他們通常會更多地關注主要指數中包含的公司。
Shenzhen Mindray Bio-Medical Electronics already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shenzhen Mindray Bio-Medical Electronics' earnings history below. Of course, the future is what really matters.
深圳邁瑞生物醫療電子已經在股份登記處設立了機構。事實上，他們擁有該公司可觀的股份。這意味着在這些機構工作的分析師已經看過這隻股票，他們很喜歡。但是就像其他人一樣，他們可能錯了。如果多家機構同時改變對股票的看法，你可能會看到股價快速下跌。因此，值得在下面查看深圳邁瑞生物醫療電子的收益記錄。當然，未來才是真正重要的。
Hedge funds don't have many shares in Shenzhen Mindray Bio-Medical Electronics. Our data shows that Xiting Li is the largest shareholder with 27% of shares outstanding. Hang Xu is the second largest shareholder owning 25% of common stock, and Cheng Minghe holds about 4.4% of the company stock. Cheng Minghe, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.
對沖基金在深圳邁瑞生物醫療電子的股份不多。我們的數據顯示，李希廷是最大股東，已發行股份的27％。徐航是第二大股東，擁有25％的普通股，程明和持有公司約4.4％的股份。第三大股東程明和也恰好擁有董事會成員的頭銜。
To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.
爲了使我們的研究更有趣，我們發現前兩名股東擁有公司的多數股權，這意味着他們足夠強大，足以影響公司的決策。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.
雖然研究公司的機構所有權可以爲你的研究增加價值，但研究分析師的建議以更深入地了解股票的預期表現也是一種很好的做法。有很多分析師報道該股，因此可能也值得一看他們的預測。
Insider Ownership Of Shenzhen Mindray Bio-Medical Electronics
深圳邁瑞生物醫療電子的內部所有權
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
儘管內部人員的確切定義可能是主觀的，但幾乎所有人都認爲董事會成員是內部人士。公司管理層對董事會的回答，董事會應代表股東的利益。值得注意的是，有時高層管理人員自己也在董事會中。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
當內部所有權表明領導層的思維方式與公司的真正所有者一樣時，內部所有權是積極的。但是，較高的內部所有權也可以爲公司內部的一小部分人提供巨大的權力。在某些情況下，這可能是負面的。
Our most recent data indicates that insiders own the majority of Shenzhen Mindray Bio-Medical Electronics Co., Ltd.. This means they can collectively make decisions for the company. Given it has a market cap of CN¥370b, that means insiders have a whopping CN¥207b worth of shares in their own names. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if they have been selling down their stake.
我們的最新數據表明，內部人士擁有深圳邁瑞生物醫療電子有限公司的大部分股份。這意味着他們可以共同爲公司做出決策。鑑於其市值爲370億元人民幣，這意味着內部人士以自己的名義擁有高達2070億元人民幣的股票。大多數人會認爲這是積極的，顯示出與股東的強烈一致性。您可以點擊此處查看他們是否一直在出售其股份。
General Public Ownership
一般公有制
With a 16% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Shenzhen Mindray Bio-Medical Electronics. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
深圳邁瑞生物醫療電子擁有 16% 的所有權，大衆對深圳邁瑞生物醫療電子有一定程度的影響力，主要是個人投資者。儘管這個群體不一定能做主，但它肯定會對公司的運作方式產生真正的影響。
Private Company Ownership
私人公司所有權
We can see that Private Companies own 11%, of the shares on issue. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
我們可以看到，私人公司擁有11％的已發行股份。私營公司可能是關聯方。有時，內部人士通過控股私營公司而對上市公司擁有權益，而不是以個人身份擁有權益。儘管很難得出任何寬泛的結論，但值得注意的是，這是一個需要進一步研究的領域。
Next Steps:
後續步驟：
While it is well worth considering the different groups that own a company, there are other factors that are even more important. Case in point: We've spotted 1 warning sign for Shenzhen Mindray Bio-Medical Electronics you should be aware of.
儘管值得考慮擁有公司的不同群體，但還有其他因素更爲重要。一個很好的例子：我們發現了你應該注意的深圳邁瑞生物醫療電子的1個警告信號。
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
如果你想了解分析師對未來增長的預測，千萬不要錯過這份關於分析師預測的免費報告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意：本文中的數字是使用過去十二個月的數據計算得出的，這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎？對內容感到擔憂？直接聯繫我們。 或者，給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論，我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議，也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意，我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之，華爾街沒有持有任何上述股票的頭寸。
譯文內容由第三人軟體翻譯。